Episode 685: Episode 26-28 Who are the Lost Women of Science???

Episode 685: Episode 26-28 Who are the Lost Women of Science???

On this week’s Tech Nation, Moira speaks with former New York Times journalist Katie Hafner about the Lost Women of Science initiative and what they’re doing to find and share the stories of women in science whose work has gone unrecognised. Then, CEO Lisa Deschamps tells us how Aviado Bio is working to correct the gene driving many cases of frontotemporal dementia.

Episode 684: Episode 26-27 Biotech in the Balance

On this week’s Tech Nation, Moira speaks with Physician and Entrepreneur, Dr. Jeremy Levin, about the big picture of biotech - and how it affects us all. They discuss the challenges facing the industry today: from global pandemics to funding cuts, to politics influencing innovation - and what it means for the future of health in the US. Dr. Levin’s book is, “Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust”

Episode 683: Episode 26-26 Some People Are Just Anointed !!!

On this week’s Tech Nation, UC Berkeley Business and Entrepreneurship Professor, Dr. Toby Stuart, has studied the "Anointed" – those people who seem to get all the "good stuff". You'll learn how to recognise it. His book is “Anointed … The Extraordinary Effects of Social Status in a Winner-Take-Most World”.

Episode 682: Episode 26-25 Why Good Companies Go Bad

On this week’s Tech Nation, what sets a great company apart from the rest? Moira speaks with Eric Ries about his book, “Incorruptible: Why Good Companies Go Bad and How Great Companies Stay Great”. Then, Dr. Steve Harr tells us how Sana Biotechnology is working to engineer insulin-producing cells for Type I diabetics, without the need for immunosuppressant drugs.

Episode 681: Episode 26-24 A Biotech Breakthrough in Antivenom

On this week’s Tech Nation, Biotech Entrepreneur, Dr. Jake Glanville, Founder, Chair and CEO of Centivax, gives us the insider’s view of the first real breakthrough in snake antivenom in 125 years, all thanks to a man who's been bitten by over 200 venomous snakes. Then, Robert Blum, CEO of CytoKinetics, shares the latest in heart failure treatment and what it could mean for extending quality of life.